Showing posts with label
Verve
.
Show all posts
Showing posts with label
Verve
.
Show all posts
Thursday, August 28, 2025
BEAM Therapeutics - A simplified investor report!
›
Beam Therapeutics (NASDAQ: BEAM) Simplified Investor Report – August 2025 1. What Beam Does Beam is a gene-editing company that uses ...
Friday, May 24, 2024
Editas Medicine and CRISPR Therapeutics are both gene-editing companies that focus on developing therapies using CRISPR-Cas9 technology.
›
Let’s explore their differences and where they stand in terms of DNA editing technology: Editas Medicine : Market Cap : Approximately $4...
›
Home
View web version
